Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000583412 | SCV000691528 | likely benign | Hereditary cancer-predisposing syndrome | 2017-10-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001619803 | SCV001843764 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001809684 | SCV002057420 | likely benign | Peutz-Jeghers syndrome | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001809684 | SCV002383077 | likely benign | Peutz-Jeghers syndrome | 2024-01-18 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV001809684 | SCV004824031 | likely benign | Peutz-Jeghers syndrome | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000583412 | SCV004849314 | uncertain significance | Hereditary cancer-predisposing syndrome | 2015-12-04 | criteria provided, single submitter | clinical testing | The c.598-14C>T intronic alteration consists of a C to T substitution 14 nucleotides before coding exon 5 in the STK11 gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |